ImmunologyJournal for ImmunoTherapy of CancerPeer-reviewed
TIM-3 blockade enhances ex vivo stimulated allogeneic NK cell therapy for relapsed murine neuroblastoma after hematopoietic cell transplant
Aicha E. Quamine, Evan L. Dray, Nicholas R Mohrdieck…·Christian M. Capitini
This study shows that combining TIM-3 blockade with ex vivo stimulated allogeneic NK cells improves survival and reduces tumor growth in a murine neuroblastoma model after allo-HCT without increasing GVHD.
2 citations